Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Feb 9, 2010


Sirshendu Roopom Banerjee has been appointed as president and CEO of RainDance Technologies. He replaces Chris McNary, who will stay with the company as chief commercial officer.

Most recently, Banerjee was a director of healthcare investment banking at Leerink Swann, where he covered the life science tools and diagnostics sector. Prior to that, he held advisory positions at McKinsey and Goldman Sachs. Banerjee holds an MPP degree from the Kennedy School of Government at Harvard University and dual BS degrees in biology and economics from the Massachusetts Institute of Technology.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.